{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:21:01Z","timestamp":1793326861873,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.surg.2025.109698","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:23:03Z","timestamp":1759789383000},"page":"109698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-4343","authenticated-orcid":false,"given":"Justin","family":"Bauzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilman","family":"Plitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Perez-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Berber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine B.","family":"Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Siperstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Romero-Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109698_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211000251","article-title":"Advancements in the treatment of differentiated thyroid cancer","volume":"12","author":"Stewart","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.surg.2025.109698_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ijc.33690","article-title":"Thyroid cancer, recent advances in diagnosis and therapy","volume":"149","author":"Nabhan","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2025.109698_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.suc.2019.04.003","article-title":"Extent of surgery for low-risk differentiated thyroid cancer","volume":"99","author":"McDow","year":"2019","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.surg.2025.109698_bib4","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.3390\/cancers12113282","article-title":"Thyroid lobectomy for low to intermediate risk differentiated thyroid cancer","volume":"12","author":"Hartl","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109698_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.649522","article-title":"Thyroseq v3, Afirma GSC, and microRNA panels versus previous molecular tests in the preoperative diagnosis of indeterminate thyroid nodules: a systematic review and meta-analysis","volume":"12","author":"Silaghi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.surg.2025.109698_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2018.0733","article-title":"Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules","volume":"29","author":"Endo","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2025.109698_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CCO.0000000000000414","article-title":"An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer","volume":"30","author":"Nicholson","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.surg.2025.109698_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamasurg.2016.0825","article-title":"Molecular-directed treatment of differentiated thyroid cancer: advances in diagnosis and treatment","volume":"151","author":"Yip","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2025.109698_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00268-019-05189-3","article-title":"Need for completion thyroidectomy in patients undergoing lobectomy for indeterminate and high-risk nodules: impact of intra-operative findings and final pathology","volume":"44","author":"Moore","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2025.109698_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2025.109698_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.surg.2016.05.056","article-title":"Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine","volume":"161","author":"Kluijfhout","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109698_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.surg.2025.109698_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","article-title":"Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer","volume":"149","author":"Schumm","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.surg.2025.109698_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.surg.2022.05.048","article-title":"Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes","volume":"173","author":"Liu","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109698_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/EJE-13-0944","article-title":"Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma","volume":"170","author":"Danilovic","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2025.109698_bib16","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1158\/0008-5472.CAN-17-0448","article-title":"Precision oncology: between vaguely right and precisely wrong","volume":"77","author":"Brock","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2025.109698_bib17","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.3390\/cancers13205184","article-title":"Molecular signature expands the landscape of driver negative thyroid cancers","volume":"13","author":"Bim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109698_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.surg.2025.109698_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/107327480601300205","article-title":"Genetic considerations in thyroid cancer","volume":"13","author":"Patel","year":"2006","journal-title":"Cancer Control"},{"key":"10.1016\/j.surg.2025.109698_bib20","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/0008-5472.CAN-03-3811","article-title":"Using gene expression profiling to differentiate benign versus malignant thyroid tumors","volume":"64","author":"Mazzanti","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2025.109698_bib21","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.onc.1210792","article-title":"Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information","volume":"27","author":"Montero-Conde","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.surg.2025.109698_bib22","first-page":"1039","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2025.109698_bib23","article-title":"Sodium iodide symporter (NIS) expression in cytologically indeterminate and malignant thyroid nodules [abstract]","volume":"33","author":"Santhanam","year":"2023","journal-title":"Thyroid"},{"issue":"suppl 1","key":"10.1016\/j.surg.2025.109698_bib24","article-title":"mRNA expression based tumor behavior prediction models in thyroid nodules [abstract]","volume":"7","author":"Golding","year":"2023","journal-title":"JES"},{"key":"10.1016\/j.surg.2025.109698_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"suppll 1","key":"10.1016\/j.surg.2025.109698_bib26","article-title":"Retrospective analysis of mRNA expression based signatures of thyroid tumor invasion and metastases [abstract]","volume":"8","author":"Ahmadi","year":"2024","journal-title":"JES"},{"key":"10.1016\/j.surg.2025.109698_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/CBM-181758","article-title":"Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma","volume":"24","author":"Reyes","year":"2019","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.surg.2025.109698_bib28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/15353702211008809","article-title":"Identification of key biomarkers for thyroid cancer by integrative gene expression profiles","volume":"246","author":"Tian","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.surg.2025.109698_bib29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s12885-016-2771-6","article-title":"Development of prognostic signatures for intermediate-risk papillary thyroid cancer","volume":"16","author":"Brennan","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.surg.2025.109698_bib30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.surg.2025.109698_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.surg.2025.109698_bib32","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/cancers11091230","article-title":"Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients","volume":"11","author":"Medas","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109698_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/thy.2019.0274","article-title":"The identification of intraoperative risk factors can reduce, but not exclude, the need for completion thyroidectomy in low-risk papillary thyroid cancer patients","volume":"30","author":"Craig","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2025.109698_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1568008043339839","article-title":"The sodium-iodide symporter","volume":"4","author":"Baker","year":"2004","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.surg.2025.109698_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2265.2011.04032.x","article-title":"Use of sodium iodide symporter expression in differentiated thyroid carcinomas","volume":"75","author":"Morari","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2025.109698_bib36","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2007-0353","article-title":"Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining","volume":"93","author":"Sodr\u00e9","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2025.109698_bib37","first-page":"1188","article-title":"Sodium iodide symporter: its role in nuclear medicine","volume":"43","author":"Chung","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.surg.2025.109698_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ando.2022.08.002","article-title":"Effect of thyroid nodule size on cytology reliability and incidence of malignancy: a large cohort of 1205 patients from a single center","volume":"84","author":"Sencar","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.surg.2025.109698_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.amjsurg.2016.10.028","article-title":"Are large thyroid nodules classified as benign on fine needle aspiration more likely to harbor cancer?","volume":"213","author":"Shi","year":"2017","journal-title":"Am J Surg"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025005501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025005501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:27:54Z","timestamp":1780201674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606025005501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0039606025005501"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109698","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109698"}}